Novai Investors
Novai is a disruptive British biotech start-up with an AI supported retinal biomarker for use in glaucoma and AMD clinical trials.
Industry:
Healthcare Company
Headquarters:
Reading, Reading, United Kingdom
Investor Type:
Healthcare Company
Founded Date:
2020

